Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Keynote Chat: Navigating VC Investment, Focus, & Trends
TVM Capital Life Science
Wendy Nelson, CEO, LeadingBiotech
What kind of people are needed to make a successful, sustainable biotech? What changes are needed to encourage, recruit and retain a robust life science community throughout Europe?
Look at the difference between going public in Europe vs the US for European-based biotech companies, current trends, and the implications for listing
What are the elements of a successful partnership, and what lessons can be learned to avoid often overlooked mis-steps?
How are stakeholders acting towards creating long term value in the life science community in Europe? How must biotech builders think about their path forward, from compelling science to commercial strategy?
What are some of the valuable growth strategies and survival techniques in the early stages of biotech development? Hear other biotech perspectives from peers in various stages of growth and development.
Gain candid insight via a remarkable story of Merck spin-off Prexton Therapeutics, including a fascinating exit with the 2018 sale of the company to Lundbeck.
Asses the latest developments in Oncology from Cell & Gene Therapy, technology enabling Precision Medicine to the latest in CarT & Immunotherapy. What kind of evidence do you need for regulatory approval, to bring an oncology treatment to market in Europe?
In April 2018, Alexion Pharmaceuticals announced an acquisition of a biopharmaceutical company based in Stockholm, Sweden. Sit in for a special “exit story” told by former Founder & CEO of Wilson Pharma
What are the key success factors to compete in a global market? Take a closer look at Europe in the context of the “big picture”